CIBER BBN

What CIBER BBN does

CIBER-BBN (Consorcio Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina, M.P.) is a Spanish public research consortium operating as a thematic area within the CIBER (Centro de Investigación Biomédica en Red) network under the Instituto de Salud Carlos III (ISCIII). Its mission is to promote and connect biomedical research in three areas: Bioengineering and Medical Imaging, Biomaterials and Advanced Therapies, and Nanomedicine. The consortium coordinates 41+ research groups and clinical groups distributed across Spanish institutions, headquartered in Madrid.

The consortium's core technology infrastructure centers on NANBIOSIS, a designated Singular Scientific and Technical Infrastructure (ICTS) providing standardized biomaterial and nanomedicine production and characterization services. CIBER-BBN also operates a technology pipeline (Pipeline CIBER-BBN – Oferta Tecnológica) for technology licensing and collaborative R&D, a transversal Training and Capacity Building program, and an Internationalization Platform. Ongoing cross-CIBER joint project calls link CIBER-BBN to sister consortia in cardiovascular, infectious, neurodegenerative, hepatic, rare disease, and epidemiology domains.

CIBER-BBN is a non-profit entity with no commercial product sales. Its revenue model is institutional public funding from the Spanish Ministry of Science and Innovation through ISCIII, supplemented by competitive grants, EU structural funds, and sponsorship from industry partners (notably Boehringer Ingelheim and Fundación Sabadell). Activities are delivered through competitive grant calls, scientific forums, annual CIBER-BBN Days, Young Scientist Forums, Clinical Forums, and bilateral industry-academic collaboration forums. The consortium is governed by a Board of Directors (Consejo Rector), a Scientific Direction Committee, and an External Scientific Advisory Committee.

Name

CIBER BBN

Legal name

CONSORCIO CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED

Website

https://ciber-bbn.es

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

501–1,000 employees

Short description

CIBER-BBN is a Spanish public research consortium under ISCIII that coordinates 41+ research and clinical groups across Spain in bioengineering, biomaterials, and nanomedicine. It operates the NANBIOSIS ICTS infrastructure platform and is funded by the Spanish Ministry of Science and Innovation.

Ownership category

akta.pro rank

Headquarters

HQ city

Madrid

HQ country

Spain

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Public Research Funding: CIBER-BBN is a public consortium primarily funded by the Instituto de Salud Carlos III (ISCIII) and the Spanish Ministry of Science and Innovation. The consortium receives institutional funding to support research groups and collaborative projects.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

CIBER-BBN is a public Spanish research consortium that coordinates basic, translational, and clinical research in bioengineering, medical imaging, biomaterials, advanced therapies, and nanomedicine. It operates the NANBIOSIS ICTS research infrastructure platform and delivers technology transfer services, training programs, and collaborative research projects across its network of 41+ research and clinical groups distributed across Spanish institutions.

Product overview

CIBER BBN is a Spanish biomedical research consortium specializing in bioengineering, biomaterials, and nanomedicine. The consortium operates as a multi-platform research organization comprising three main research programs (Bioengineering and Medical Imaging, Biomaterials and Advanced Therapies, and Nanomedicine), supported by the NANBIOSIS ICTS infrastructure platform. The organization offers technology transfer services through its Transferencia Industrial program, maintains a technology pipeline (Pipeline CIBER-BBN), and provides training programs for researchers. The consortium functions as an integrated network of research groups across Spain rather than a single product company.

Differentiator

Problem solved

Functional benefit

Brands

• NANBIOSIS: ICTs (Singular Scientific and Technical Infrastructures) platform for nanomedicine research

Products and services

• NANBIOSIS ICTS A research infrastructure platform within NANBIOSIS ICTS that provides standardized biomaterial and nanomedicine production and advanced characterization services for biomedical researchers and industry partners.
• Bioingeniería e Imagen Médica Research program focused on bioengineering and medical imaging technologies for diagnostic and therapeutic applications, conducted by affiliated research groups across Spain.
• Biomateriales y Terapias Avanzadas Research program developing advanced biomaterials and therapeutic approaches, including regenerative medicine and advanced therapies, for medical applications.
• Nanomedicina Research program dedicated to nanotechnology-based medical treatments and drug delivery systems, supporting diagnostic and therapeutic nanomedicine applications.
• Transferencia Industrial Industrial transfer program connecting consortium research with industry through forums, transfer projects, and technology offerings for pharmaceutical, medical device, and biotech partners.
• Pipeline CIBER-BBN - Oferta Tecnológica Technology pipeline catalog showcasing the consortium's available technologies for licensing or collaboration with industry partners.
• Formación y Capacitación Training and education program offering courses and workshops on scientific communication, dissemination, and AI applications in healthcare research for researchers and young scientists.

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Partnerships

Eight partnerships are on record, tiered core and moderate.

• Instituto de Salud Carlos III (ISCIII)coreStrategic or Co-development PartnerCIBER-BBN is funded through ISCIII as part of the CIBER (Biomedical Research Centers) network. ISCIII provides institutional funding and coordinates national biomedical research programs.
• Ministerio de Ciencia e InnovacióncoreStrategic or Co-development PartnerThe Spanish Ministry of Science and Innovation provides policy direction and funding support for CIBER-BBN as a public research consortium.
• CIBER de Enfermedades Cardiovasculares (CIBERCV)moderateStrategic or Co-development PartnerJoint intramural projects program promoting collaboration between CIBER-BBN and CIBERCV researchers. Maximum 2 projects with 2-year duration.
• CIBER de Enfermedades Infecciosas (CIBERINFEC)moderateStrategic or Co-development PartnerCollaborative projects call (2024, 2025) requiring participation of at least one group from each area. Maximum 35,000€ per project (17,500€ per area), 12-24 month duration.
• CIBER de Enfermedades Neurodegenerativas (CIBERNED)moderateStrategic or Co-development PartnerCollaborative projects promoting research on innovative solutions for neurodegenerative diseases. Maximum 35,000€ per project, 24-month duration.
• CIBER de Enfermedades Hepáticas y Digestivas (CIBEREHD)moderateStrategic or Co-development PartnerJoint collaboration projects between CIBER-BBN and CIBEREHD. Maximum 2 projects with 35,000€ funding (17,500€ per area), 12-month duration.
• CIBER de Enfermedades Raras (CIBERER)moderateStrategic or Co-development PartnerNanoTER 2024 call for advanced therapies based on non-viral vectors for rare diseases. Total funding up to 200,000€, 2-year execution period.
• CIBER de Epidemiología y Salud Pública (CIBERESP)moderateStrategic or Co-development PartnerMeeting for Research Excellence in Public Health 2024, organized in collaboration with CIBER-BBN.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• CIBERDEM (Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas): Sibling thematic area within the CIBER network under ISCIII. Shares consortium governance and ISCIII funding model, focused on diabetes and metabolic disease research; comparable operational scale and structure to CIBER-BBN.
• CIBERCV (Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares): Sibling thematic area within the same CIBER network under ISCIII. Shares the consortium model, governance structure, and funding source as CIBER-BBN, focused on cardiovascular research — and is an active documented collaboration partner via joint intramural project calls.
• CIBERFES (Centro de Investigación Biomédica en Red de Fragilidad y Envejecimiento Saludable): Sibling thematic area within CIBER network under ISCIII. Same consortium model, ISCIII funding, and governance; focused on frailty and healthy aging research. Mentioned in CIBER-BBN data as the group directing a generative AI course applied to nursing research processes.
• CIBEREHD (Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas): Sibling thematic area within CIBER network under ISCIII. Same consortium structure and funding pipeline; collaborates with CIBER-BBN on joint intramural projects (up to €35k, 12-month duration) bridging biomaterials/nanomedicine with hepatic and digestive disease research.
• CIBERNED (Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas): Sibling thematic area within CIBER network under ISCIII. Shares organizational structure, funding model, and governance; collaborates with CIBER-BBN on joint projects for innovative neurodegenerative disease solutions (up to €35k per project).
• CIBERINFEC (Centro de Investigación Biomédica en Red de Enfermedades Infecciosas): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and collaborates with CIBER-BBN through joint project calls (2024, 2025) at up to €35k per project requiring cross-area participation.
• CIBERER (Centro de Investigación Biomédica en Red de Enfermedades Raras): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and partners with CIBER-BBN on the NanoTER advanced therapies call (up to €200k) for rare diseases, making it a direct structural and operational peer.
• CIBERSAM (Centro de Investigación Biomédica en Red de Salud Mental): Sibling thematic area within CIBER network under ISCIII. Operates the same consortium model and institutional framework; comparable scale and structure to CIBER-BBN but focused on mental health research.
• CIBERESP (Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública): Sibling thematic area within CIBER network under ISCIII. Same institutional structure and funding source; collaborates with CIBER-BBN on the Meeting for Research Excellence in Public Health 2024, demonstrating cross-consortium engagement.
• CIBEROBN (Centro de Investigación Biomédica en Red de Fisiopatología de la Obesidad y Nutrición): Sibling thematic area within CIBER network under ISCIII. Same consortium organizational structure and public funding model; operates with comparable group network structure focused on obesity and nutrition research.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/ciberbbn
• Instagraminstagram.com/consorcio_ciber
• LinkedInlinkedin.com/company/ciber-bbn

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CIBER BBN